Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
56.47 (1y: +124%)
Market Cap 85.02 B P/E(ttm) 31.80
Enterprise Value 91.29 B P/B 9.10
GILD- NAS (USA)
Gilead Sciences Inc
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$56.47
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,023Revenue $M9,952Net Margin (%)26.7Z-Score5.5
Enterprise Value $M91,291EPS $1.9Operating Margin %41.3F-Score7
P/E(ttm))31.8Cash Flow Per Share $4.3Pre-tax Margin (%)37.2Higher ROA y-yY
Price/Book9.110-y EBITDA Growth Rate %0Quick Ratio5.0Cash flow > EarningsY
Price/Sales9.15-y EBITDA Growth Rate %16.3Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow17.4y-y EBITDA Growth Rate %9.8ROA % (ttm)12.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)27.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M1,522ROI % (ttm)17.3Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
Total Records: 82   Page:1 2 3 4 5 Next Page
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
GILDMario Gabelli 2013-03-31 Add$36.725 - $48.94
($41.75)		 $ 56.4735%Add 119.89%27,200
GILDJohn Burbank 2013-03-31 Sold Out -0.3%$36.725 - $48.94
($41.75)		 $ 56.4735%Sold Out0
GILDJohn Hussman 2013-03-31 Reduce-0.14%$36.725 - $48.94
($41.75)		 $ 56.4735%Reduce -20.29%558,000
GILDJoel Greenblatt 2013-03-31 Reduce-0.05%$36.725 - $48.94
($41.75)		 $ 56.4735%Reduce -70.85%9,784
GILDGeorge Soros 2013-03-31 Sold Out -0.02%$36.725 - $48.94
($41.75)		 $ 56.4735%Sold Out0
GILDJohn Griffin 2012-12-31 Add0.45%$32.43 - $38.17
($35.66)		 $ 56.4758%Add 12.36%4,000,000
GILDJohn Burbank 2012-12-31 Buy 0.3%$32.43 - $38.17
($35.66)		 $ 56.4758%New holding, 104900 sh.104,900
GILDMario Gabelli 2012-12-31 Buy $32.43 - $38.17
($35.66)		 $ 56.4758%New holding, 6185 sh.6,185
GILDVanguard Health Care Fund 2012-12-31 Reduce-0.48%$32.43 - $38.17
($35.66)		 $ 56.4758%Reduce -32.28%3,482,100
GILDJoel Greenblatt 2012-12-31 Reduce-0.25%$32.43 - $38.17
($35.66)		 $ 56.4758%Reduce -77.14%16,784
GILDGeorge Soros 2012-09-30 Buy 0.03%$25.34 - $33.89
($28.46)		 $ 56.4798%New holding, 25000 sh.25,000
GILDRonald Muhlenkamp 2012-09-30 Sold Out -3%$25.34 - $33.89
($28.46)		 $ 56.4798%Sold Out0
GILDVanguard Health Care Fund 2012-09-30 Reduce-0.49%$25.34 - $33.89
($28.46)		 $ 56.4798%Reduce -29%5,142,100
GILDJohn Hussman 2012-09-30 Reduce-0.29%$25.34 - $33.89
($28.46)		 $ 56.4798%Reduce -46.15%350,000
GILDJohn Griffin 2012-06-30 Add0.89%$22.79 - $26.88
($24.95)		 $ 56.47126%Add 38.55%4,115,000
GILDJoel Greenblatt 2012-06-30 Reduce-0.29%$22.79 - $26.88
($24.95)		 $ 56.47126%Reduce -45.82%81,707
GILDJohn Burbank 2012-06-30 Sold Out -0.21%$22.79 - $26.88
($24.95)		 $ 56.47126%Sold Out0
GILDDodge & Cox 2012-06-30 Sold Out -0.0012%$22.79 - $26.88
($24.95)		 $ 56.47126%Sold Out0
GILDRonald Muhlenkamp 2012-03-31 Add1.86%$21.01 - $28.01
($22.41)		 $ 56.47152%Add 553.12%252,495
GILDJohn Griffin 2012-03-31 Add1.32%$21.01 - $28.01
($22.41)		 $ 56.47152%Add 121.64%2,970,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 82   Page:1 2 3 4 5 Next Page

GILD is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GILD Mario Gabelli 2013-03-3127,20000.01+119.89%
GILD Jean-Marie Eveillard 2013-03-3140000
GILD John Griffin 2013-03-318,000,0000.534.9
GILD Vanguard Health Care Fund 2013-03-316,721,6000.441.3-3.48%
GILD John Hussman 2013-03-31558,0000.041-20.29%
GILD Joel Greenblatt 2013-03-319,78400.02-70.85%
GILD John Burbank 2013-03-31000Sold Out
GILD George Soros 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARTIN JOHN CChairman and CEO 2013-05-01Sell282,242$50.1712.66view
Alton Gregg HEVP, Corp & Med Affairs 2013-05-01Sell30,000$50.212.59view
Washington Robin LSVP, CFO 2013-04-11Sell968$50.212.59view
MARTIN JOHN CChairman and CEO 2013-04-01Sell282,242$48.317.02view
Washington Robin LSVP, CFO 2013-04-01Sell13,000$48.3316.95view
Alton Gregg HEVP, Corp & Med Affairs 2013-04-01Sell30,000$48.3716.85view
Washington Robin LSVP, CFO 2013-03-27Sell45,000$47.0720.08view
Washington Robin LSVP, CFO 2013-03-14Sell4,304$45.8523.27view
Washington Robin LSVP, CFO 2013-03-05Sell54,800$44.2827.64view
MARTIN JOHN CChairman and CEO 2013-03-01Sell282,242$43.1431.02view

Press Releases about GILD:

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Activision Blizzard, Nielsen Holdings NV, Gilead Sciences, Autodesk Apr 08 2013 
WEEKLY CFO SELLS HIGHLIGHT: ANIK, GILD, PETM, NKE, ADBE Mar 31 2013 
Stevie Cohen On Board with Real Estate Betting, Despite SEC Probe Jan 18 2013 
Weekly Top Insider Sells: NOW, FB, GILD, and ISRG Nov 26 2012 
Weekly Top Insider Sells： AAPL, GILD, BMRN, and PCLN Nov 19 2012 
Wedgewood Partners' David Rolfe Comments on Gilead Sciences Nov 12 2012 
Wedgewood Partners Third Quarter 2012 Review and Outlook Nov 12 2012 
Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL Sep 24 2012 
FDA's Truvada Approval Seals Gilead's Leading Position Jul 20 2012 

More From Our Partners
Pipeline Progress at Gilead - Analyst Blog May 16 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK